Moderna Inc. Stock Slips 23.5%, Underperforms Peers
Dow Jones2026/08/20 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.
Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.
Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro drifts toward the bottom of its range as US rate bets climb
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Crypto prices
More
